Calcified Tissue International

, Volume 34, Issue 1, pp 553–557 | Cite as

Maintenance of normocalcemia by continuous infusion of the synthetic bovine parathyroid hormone (1–34) in parathyroidectomized rats

  • Muawia M. Ibrahim
  • Leonard R. Forte
  • Mary L. Thomas
Laboratory Investigations


This work was conducted to estimate the replacement dose of the synthetic bovine parathyroid hormone [PTH(1–34)] that is required for maintenance of serum calcium (Ca) in parathyroidectomized (PTX) rats. Male rats were PTX and used in this study only if serum Ca was reduced to at least 7 mg/dl. We found that a solution of 2% cysteine, 150 mM NaCl, and 1 mM HCl was superior to 20 mM acetic acid for maintenance of biological activity of PTH (1–34) in situ during the period of hormone infusion studied. The PTH dose—calcemic response relationship was investigated using PTH in doses of 0.6, 1, and 3 U/h. The infusion of 1 U PTH per hour raised Ca to the normal level, whereas rats infused with 0.6 U/h were hypocalcemic and 3 U/h resulted in marked hypercalcemia. To extend this observation we carried out an infusion of 1 U PTH per hour for 14 days. We found that this infusion rate of bovine PTH (1–34) provided a relatively stable level of serum calcium with modest fluctuation from normocalcemic to somewhat hypercalcemic levels for the entire 14-day period of PTH infusion. Serum calcitonin was also elevated during the infusion period and then returned to the initial level when PTH treatment was stopped. After the minipumps containing PTH were removed, the serum Ca dropped rapidly to 5 mg/dl, which was significantly lower than the control (vehicle-infused) or initial values of serum Ca (7 mg/dl). Infusion of PTH at 3 U/h for 4 days did not produce this rebound hypocalcemia after the pumps were removed. Serum Ca in those experiments returned to the initial level after hormone treatment was discontinued.

Key words

Serum calcium Parathyroidectomized rat Parathyroid hormone 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Keutmann HT, Aurbach GD, Dawson BF, Niall HD, Deftos LJ, Potts JT Jr (1971) Isolation and characterization of the bovine parathyroid hormone. Biochemistry 10:2779–2787CrossRefPubMedGoogle Scholar
  2. 2.
    Keutmann, HT, Dawson BF, Aurbach GD, Potts JT Jr (1972) A biologically active amino-terminal fragment of bovine parathyroid hormone prepared by dilute acid hydrolysis. Biochemistry 14:1973–1980CrossRefGoogle Scholar
  3. 3.
    Potts JT Jr, Tregear GW, Keutmann HT, Niall HD, Sauer R, Deftos LJ, Dawson BF, Hogan ML, Aurbach GD (1971) Synthesis of biologically active N-terminal tetratriacontapeptide of parathyroid hormone. Proc Natl Acad Sci USA 68:63–67PubMedGoogle Scholar
  4. 4.
    Obie JF, Cooper CW (1979) Loss of calcemic effects of calcitonin and parathyroid hormone infused continuously into rats using the Alzet osmotic minipump. J Pharmac Exp Ther 209:422–428Google Scholar
  5. 5.
    Marcus R, Aurbach GD (1969) Bioassay of parathyroid hormonein vitro with a stable preparation of adenylate cyclase from rat kidney. Endocrinology 85:801–810PubMedGoogle Scholar
  6. 6.
    Anast CS, David L, Winnacker J, Glass R, Baskin W, Brubaker L, Burns T (1975) Serum calcitonin lowering effect of magnesium in patients with medullary carcinoma of the thyroid. J Clin Invest 56:1615–1621PubMedCrossRefGoogle Scholar
  7. 7.
    Snedecor GW, Cochran WG (1967) Statistical Methods, 6th ed. Iowa State University Press, Ames, p 59Google Scholar
  8. 8.
    Nickols GA, Carnes DL, Anast CS, Forte LR (1979) Parathyroid hormone-mediated refractoriness of rat kidney cyclic AMP system. Am J Physiol 236:E-401–E-409Google Scholar
  9. 9.
    Tregear GW, Rietschoten JV, Greene E, Keutmann HT, Niall HD, Reit B, Parsons JA, Potts JT Jr (1973) Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity. Endocrinology 93:1349–1353PubMedCrossRefGoogle Scholar
  10. 10.
    DiBella FP, Arnaud CD, Brewer HB Jr (1976) Relative biologic activities of human and bovine parathyroid hormones and their synthetic NH2-terminal (1–34) peptides, as evaluatedin vitro with renal cortical adenylate cyclase obtained from three different species. Endocrinology 99:429–436Google Scholar
  11. 11.
    Herrmann-Erlee MPM, van der Meer JM, Hekkelman JW (1980)In vitro studies of the adenosine 3′,5′-monophosphate (cAMP) response of embryonic rat calvaria to bovine parathyroid hormone-(1–84) (b PTH-(1–84)), bPTH-(1–34), and bPTH-(3–34) and the loss of cAMP responsiveness after prolonged incubation. Endocrinology 106:2013–2018PubMedGoogle Scholar
  12. 12.
    Takahashi H, Shimazawa E, Horiuchi N, Suda T, Yamashita K, Ogata E (1978) An estimation of the parathyroid secretion rate in vitamin D deficient rats. Horm Metab Res 10:161–167PubMedCrossRefGoogle Scholar
  13. 13.
    Premachandra BN, Blumenthal HT (1961) A method for determination of parathyroid secretion rate in the rat. Proc Soc Exp Biol Med 107:842–845PubMedGoogle Scholar
  14. 14.
    Parfitt AM (1976) The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium, homeostasis, and metabolic bone diseases. Metabolism 25:909–955CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • Muawia M. Ibrahim
    • 1
  • Leonard R. Forte
    • 1
  • Mary L. Thomas
    • 1
  1. 1.Harry S. Truman Memorial Veterans Hospital and Department of Pharmacology, School of MedicineUniversity of MissouriColumbiaUSA

Personalised recommendations